We are live on
!
Find out more
Calamos Advisors Portfolio holdings
AUM
$28.2B
1-Year Est. Return
21.78%
This Fund
S&P 500
This Quarter
Est. Return
+1.86%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$16B
AUM Growth
+$835M
(+5.5%)
Cap. Flow
-$3.09B
Cap. Flow
% of AUM
-19.39%
Top 10 Holdings %
Top 10 Hldgs %
18%
Holding
764
New
113
Increased
285
Reduced
98
Closed
77
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ACT.PRA
ACTAVIS PLC Pfd Conv Ser A (Irl)
ACT.PRA
|
+$231M |
| 2 |
Lockheed Martin
LMT
|
+$82.6M |
| 3 |
Applied Materials
AMAT
|
+$77.5M |
| 4 |
Dollar General
DG
|
+$59.8M |
| 5 |
Comcast
CMCSA
|
+$52.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$70.9M |
| 2 |
Blackstone
BX
|
+$60.7M |
| 3 |
UTX.PRA
UNITED TECHNOLOGIES CORP CORP UNIT (DE)
UTX.PRA
|
+$59.5M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$58.8M |
| 5 |
Apple
AAPL
|
+$56.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.44% |
| 2 | Financials | 10.19% |
| 3 | Healthcare | 10.12% |
| 4 | Consumer Discretionary | 8.73% |
| 5 | Industrials | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
MGIC Investment
MTG
$6.38B
| $661K | ﹤0.01% |
68,600
+6,400
| +10% | +$58.6K |
|
|
TBI
427
Trueblue
TBI
$236M
| $659K | ﹤0.01% |
27,075
| – | – |
|
428
Core Laboratories
CLB
$521M
| $658K | ﹤0.01% |
6,300
| – | – |
|
|
VRTU
429
DELISTED
Virtusa Corporation
VRTU
| $646K | ﹤0.01% |
15,600
| – | – |
|
430
Jazz Pharmaceuticals
JAZZ
$16B
| $639K | ﹤0.01% |
3,700
+800
| +28% | +$137K |
|
|
ZINC
431
DELISTED
HORSEHEAD HLDG CORP COM STK (DE)
ZINC
| $639K | ﹤0.01% |
50,510
| – | – |
|
|
PSIX
432
Power Solutions International
PSIX
$680M
| $633K | ﹤0.01% |
9,850
| – | – |
|
433
Murphy Oil
MUR
$5.41B
| $609K | ﹤0.01% |
13,076
+8
| +0.1% | +$387 |
|
|
BEL
434
DELISTED
Belmond Ltd.
BEL
| $609K | ﹤0.01% |
49,625
| – | – |
|
435
Synaptics
SYNA
$4.44B
| $608K | ﹤0.01% |
7,475
| – | – |
|
|
INVX
436
Innovex International
INVX
$1.84B
| $596K | ﹤0.01% |
8,715
+575
| +7% | +$41.4K |
|
437
Dave & Buster's
PLAY
$357M
| $592K | ﹤0.01% |
19,420
+1,710
| +10% | +$51.1K |
|
438
Genworth Financial
GNW
$3.81B
| $588K | ﹤0.01% |
80,435
+18
| +0% | +$137 |
|
439
STAAR Surgical
STAA
$1.15B
| $574K | ﹤0.01% |
77,200
| – | – |
|
440
Calix
CALX
$2.32B
| $571K | ﹤0.01% |
68,100
+18,090
| +36% | +$162K |
|
441
A.O. Smith
AOS
$8.59B
| $568K | ﹤0.01% |
17,300
-4,600
| -21% | -$140K |
|
442
Progress Software
PRGS
$1.63B
| $565K | ﹤0.01% |
20,800
| – | – |
|
443
Alkermes
ALKS
$8.79B
| $551K | ﹤0.01% |
9,035
-4,905
| -35% | -$335K |
|
|
IMPV
444
DELISTED
Imperva, Inc.
IMPV
| $550K | ﹤0.01% |
12,870
+3,400
| +36% | +$151K |
|
|
IIP
445
DELISTED
INTERNAP NETWORK SERVICES CORPORATION
IIP
| $546K | ﹤0.01% |
53,400
| – | – |
|
|
GTT
446
DELISTED
GTT Communications, Inc.
GTT
| $544K | ﹤0.01% |
28,800
-1,900
| -6% | -$27.7K |
|
|
ECOL
447
DELISTED
US Ecology, Inc.
ECOL
| $537K | ﹤0.01% |
10,750
-5,670
| -35% | -$257K |
|
448
Ziff Davis
ZD
$1.95B
| $521K | ﹤0.01% |
+9,114
| New | +$507K |
|
449
Teradyne
TER
$51.5B
| $518K | ﹤0.01% |
27,480
+2,275
| +9% | +$43.6K |
|
450
Affiliated Managers Group
AMG
$9.55B
| $513K | ﹤0.01% |
2,387
| – | – |
|
Similar funds
PCH
N
TWC
FDCDDQ
NA
Calamos Advisors's Q1 2015 Portfolio in Review
As of Q1 2015, Calamos Advisors held 764 positions worth $16B, up 5.5% from $15.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Calamos Advisors withdrew a net $3.09B in Q1 2015, closing 77 positions and reducing 98 holdings. Its most notable exit was Harley-Davidson, an estimated $53M position sold in full.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Calamos Advisors opened a new position in ACTAVIS PLC Pfd Conv Ser A (Irl) worth $223M.
- Calamos Advisors's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 220,721 shares worth $223M.
- Calamos Advisors added most to Applied Materials in Q1 2015, an estimated $77.5M increase.
- Calamos Advisors's biggest Q1 2015 reduction was Regeneron Pharmaceuticals, cutting an estimated $70.9M.
- Calamos Advisors fully exited Harley-Davidson in Q1 2015, selling an estimated $53M.
- Calamos Advisors's ten largest holdings make up 18% of its $16B portfolio in Q1 2015.
- Calamos Advisors opened 113 new positions and closed 77 in Q1 2015.
- Calamos Advisors's portfolio value rose 5.5% quarter-over-quarter to $16B.
Based on Calamos Advisors's 13F filing for Q1 2015, filed 13 May 2015.